Transplantation: Regulating the rejection process: The search for new targets to minimise immunosuppressive therapy

Current Opinion in Immunology

Volumn 15, Issue 5, 2003, Pages 477-478

  Waldmann, Herman ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR; COMPLEMENT; COMPLEMENT INHIBITOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR;

AUTOIMMUNITY; B LYMPHOCYTE; BLOOD VESSEL; DRUG TARGETING; EDITORIAL; EFFECTOR CELL; ENDOTHELIUM CELL; GRAFT REJECTION; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; REGULATORY MECHANISM; REPERFUSION INJURY; T LYMPHOCYTE; TISSUE INJURY; TRANSPLANTATION;

EID: 0141629563     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00105-5     Document Type: Editorial

References (5)

1. Hancock WW, Wang L, Ye Q, Han R, Lee I: Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003, 15: 479-486.
2. Sacks SH, Chowdhury P, Zhou W: Role of the complement system in rejection. Curr Opin Immunol 2003, 15: 487-492.
3. Valujskikh A, Heeger PS: Emerging roles of endothelial cells in transplant rejection. Curr Opin Immunol 2003, 15: 493-498.
4. Graca L, Le Moine A, Cobbold SP, Waldmann H: Dominant transplantation tolerance. Curr Opin Immunol 2003, 15: 499-506.
5. Inverardi L, Kenyon NS, Ricordi C: Islet transplantation: immunological perspectives. Curr Opin Immunol 2003, 15: 507-511.